KACTUS Blog

TCE Antibody Screening Applying Native-like KACTUS TCR-CD3 Complexes to Drug Discovery
TCE Antibody Screening Applying Native-like KACTUS TCR-CD3 Complexes to Drug Discovery
The Landscape of GPCR-targeting Antibody Drug Development
The Landscape of GPCR-targeting Antibody Drug Development
Nanodiscs: A Versatile Platform for Membrane Protein Research
Nanodiscs: A Versatile Platform for Membrane Protein Research
Case Review: Exploring domain proteins in antibody development
Case Review: Exploring domain proteins in antibody development
MRGPRX2: A Promising Target for Antibody Discovery in Allergy and Pain Disorders
MRGPRX2: A Promising Target for Antibody Discovery in Allergy and Pain Disorders
Addressing Challenging Antibody Discovery Targets with Virus-like Particle (VLP) Transmembrane Proteins
Addressing Challenging Antibody Discovery Targets with Virus-like Particle (VLP) Transmembrane Proteins
Virus-like Particles: What they are and what they can do in Antibody Discovery
Virus-like Particles: What they are and what they can do in Antibody Discovery
TM4SF1 in Cancer Immunotherapy: Emerging Research and Clinical Potential
TM4SF1 in Cancer Immunotherapy: Emerging Research and Clinical Potential

Explore more

  • Antibody Drug Discovery
  • Assay Kits
  • Cell Therapy
  • Company News
  • Gene Editing
  • GPCRs
  • Membrane Proteins
  • MHC/TCR
  • Product Highlights
  • Recombinant Proteins
  • RNA/DNA
  • VLP & Nanodisc Proteins
  • VLP and Nanodisc Proteins
  • VLP Proteins

    • Popular posts

    Beyond Refolding: The Case for Mammalian-Expressed Single-Chain Trimer MHCs
    Beyond Refolding: The Case for Mammalian-Expressed Single-Chain Trimer MHCs
    Sep 18, 2024
    IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme
    IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme
    Jul 24, 2024